|
Loading...
| ||||||||||||||
Recent Publications by Merck Sharp & Dohme Research Laboratories: |  | |
| Topical delivery for the treatment of psoriasis.
Importance of the field: Psoriasis is one of the most common human skin... | Biopharmaceutics and Parenteral Delivery, Pharmaceutical Sciences, Merck | Expert Opin Drug Deliv. 2010 Aug;7(8):977-92.
DOI Direct Link |
| Dose selection of corifollitropin alfa by modeling and simulation in controlled ovarian stimulation.
In controlled ovarian stimulation (COS), a single subcutaneous dose of... | Global Drug Metabolism & Pharmacokinetics, Merck Research Labs, Merck | Clin Pharmacol Ther. 2010 Jul;88(1):79-87. Epub 2010 Jun 2.
DOI Direct Link |
| Effect of absorption site on the pharmacokinetics of sublingual asenapine in healthy male subjects.
Asenapine is a psychopharmacologic agent approved in the United States for... | Merck Sharp & Dohme, | Biopharm Drug Dispos. 2010 Jul;31(5-6):351-7.
DOI Direct Link |
| Antihypertensive drug development: current challenges and future opportunities.
The growing rate of obesity and diabetes, and an aging population has led... | Cardiovascular Clinical Research, Merck Sharp & Dohme Corp, a subsidiary | J Am Soc Hypertens. 2010 May 26.
DOI Direct Link |
| Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia.
BACKGROUND: Co-administration of niacin with statin offers the potential... | Merck Research Laboratories, Cardiovascular Disease, Merck, Sharp & Dohme | Int J Clin Pract. 2010 May;64(6):727-38.
DOI Direct Link |